Basic Information
| LncRNA/CircRNA Name | RP5-833A20.1 |
| Synonyms | NFIA-AS1 |
| Region | GRCh38_1:61248945-61253510 |
| Ensemble | ENSG00000237853 |
| Refseq | NR_104180 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR, Cell transfection, Western blot, Cell proliferation assay etc. |
| Sample | glioma tissues, cell line (U251) |
| Expression Pattern | down-regulated |
| Function Description | The expression of RP5-833A20.1 was downregulated, whereas the expression of NFIA was upregulated in glioma tissues, compared with corresponding adjacent nontumor tissues from 20 patients with glioma. The overexpression of RP5-833A20.1 inhibited proliferation and cell cycle progression, and induced apoptosis in the U251 cells. |
| Pubmed ID | 27779670 |
| Year | 2016 |
| Title | Long non-coding RNA RP5-833A20.1 inhibits proliferation, metastasis and cell cycle progression by suppressing the expression of NFIA in U251 cells. |
External Links
| Links for RP5-833A20.1 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |